V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 230000620 | 230000361 | 1.63 | 85 | Palliative (P) | 2014-03-16 | 2014-03-29 | Cisplatin + Pemetrexed | N | N | 230007606 | AML19 TRIAL |
| 230000621 | 230000362 | 1.81 | 72.6 | Adjuvant (A) | 2016-05-08 | 2016-05-23 | Fluorouracil + Folinic + RT Bossett | 02 | N | 230007623 | OXALIPLATIN + MDG |
| 230000622 | 230000363 | 1.51 | 69.1 | Curative (C) | null | 2015-09-19 | CAPECITABINE + OXALIPLATIN | N | N | 230007688 | DOCETAXEL |
| 230000623 | 230000364 | 1.64 | 0 | Adjuvant (A) | 2017-07-21 | 2017-07-22 | Hydroxycarbamide | 2 | N | 230007737 | PEMBROLIZUMAB |
| 230000624 | 230000365 | 1.66 | null | Adjuvant (A) | 2013-10-14 | 2013-11-12 | Erlotinib | N | null | 230007750 | VANDETANIB |
| 230000625 | 230001189 | 1.55 | 81 | Adjuvant (A) | 2013-12-30 | 2014-01-17 | FLUOROURACIL + IRINOTECAN | 02 | null | 230007770 | CAPECITABINE + RT |
| 230000626 | 230001189 | 1.84 | 77.8 | Neo-adjuvant (N) | 2013-03-22 | 2013-03-22 | Capecitabine + Oxaliplatin 21day | 99 | N | 230007770 | CISPLATIN + DOCETAXEL |
| 230000627 | 230000366 | 1.42 | 76.1 | Palliative (P) | 2017-09-04 | 2017-09-18 | Capecitabine | 02 | N | 230007808 | OXALIPLATIN + MDG |
| 230000628 | 230000366 | 1.63 | 57.2 | Palliative (P) | 2017-09-27 | 2017-10-09 | CAPECITABINE + RT | N | null | 230007808 | CAPECITABINE + RT |
| 230000629 | 230000367 | 1.59 | 89 | Not known (9) | 2017-04-11 | 2017-04-24 | Oxaliplatin + Modified de Gramont | N | N | 230007880 | EC |
| 230000630 | 230000368 | 1.76 | 93.6 | Neo-adjuvant (N) | 2017-03-19 | 2017-04-09 | CHOP R - 21 days | 02 | Y | 230007935 | CAPECITABINE |
| 230000631 | 230000369 | null | 71 | Curative (C) | 2017-03-23 | 2017-03-24 | GEFITINIB | 2 | N | 230007973 | FEC |
| 230000632 | 230000369 | 1.7 | 53.3 | Curative (C) | 2013-06-26 | 2013-07-24 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | Y | 230007973 | IPILIMUMAB + NIVOLUMAB |
| 230000633 | 230000369 | 1.71 | 61.2 | Palliative (P) | 2015-05-13 | 2015-05-28 | Erlotinib | N | null | 230007973 | CVP R |
| 230000634 | 230000370 | null | 85.2 | Palliative (P) | 2017-03-06 | 2017-03-12 | Cisplatin + Etoposide po&iv 3 day | N | N | 230008108 | OXALIPLATIN + MDG |
| 230000635 | 230000371 | 1.64 | 77.9 | Palliative (P) | 2015-03-28 | 2015-03-29 | MPT | N | N | 230008118 | CHOP R |
| 230000636 | 230000372 | 1.61 | null | Adjuvant (A) | 2016-04-19 | 2016-04-19 | Irinotecan + Modified De Gramont | 02 | N | 230008133 | CISPLATIN + DOCETAXEL |
| 230000637 | 230000373 | 1.52 | 52 | Palliative (P) | 2016-09-20 | 2016-10-11 | FLUOROURACIL + OXALIPLATIN | N | N | 230008182 | CARBOPLATIN + PACLITAXEL |
| 230000638 | 230000374 | 1.7 | 64 | Palliative (P) | 2018-10-06 | 2018-10-07 | Trial Unspecified | 2 | N | 230008211 | AFATINIB |
| 230000639 | 230000374 | 1.7 | 121.8 | null | 2017-06-04 | 2017-06-07 | Capecitabine + Oxaliplatin 21day | 1 | null | 230008211 | SORAFENIB |
| 230000640 | 230001514 | 1.69 | 69.1 | null | 2014-01-18 | 2014-01-20 | LENVATINIB | 02 | N | 230008259 | FEC |
| 230000641 | 230001514 | 1.54 | 64 | Curative (C) | 2015-08-10 | 2015-08-26 | Capecitabine | N | Y | 230008259 | OXALIPLATIN + MDG |
| 230000642 | 230000375 | 1.92 | 75.9 | Palliative (P) | 2017-04-29 | 2017-04-29 | CHOP R - 21 days | 02 | N | 230008316 | CAPECITABINE |
| 230000643 | 230000376 | 1.53 | 45.2 | Adjuvant (A) | 2018-02-06 | 2018-03-13 | Capecitabine + Oxaliplatin 21day | 02 | N | 230008351 | CISPLATIN + DOXORUBICIN |
| 230000644 | 230000377 | 1.42 | null | Curative (C) | 2016-11-12 | 2016-11-18 | CARBOPLATIN + PACLITAXEL | N | Y | 230008377 | CAPECITABINE + MITOMYCIN |
| 230000645 | 230000377 | 1.55 | 83 | Palliative (P) | 2016-04-14 | 2016-04-20 | Bendamustine +/- Prednisolone | N | N | 230008377 | GEMCITABINE + NAB-PACLITAXEL |
| 230000646 | 230000378 | 1.58 | 79.3 | Palliative (P) | 2015-08-22 | 2015-08-29 | Capecitabine | 2 | N | 230008396 | CHOP R |
| 230000647 | 230000379 | 0 | 66.4 | Disease modification (D) | 2013-08-19 | 2016-03-24 | CAPECITABINE + OXALIPLATIN | N | N | 230008401 | CAPECITABINE + MITOMYCIN |
| 230000648 | 230000380 | 1.8 | 85 | Adjuvant (A) | 2016-05-19 | 2016-05-27 | LANREOTIDE | N | N | 230008413 | CARBOPLATIN + ETOPOSIDE |
| 230000649 | 230000381 | null | 73.1 | Adjuvant (A) | 2017-03-15 | 2017-04-01 | Cisplatin +Fluorouracil (3 wk) | N | N | 230008421 | PACLITAXEL |
| 230000650 | 230000382 | 1.66 | 66.6 | Curative (C) | 2017-08-04 | 2017-08-05 | Cisplatin + Vinorelbine (PO) | 02 | Y | 230008424 | PACLITAXEL |
| 230000651 | 230001194 | 1.65 | null | Neo-adjuvant (N) | 2016-07-25 | 2016-07-31 | VANDETANIB | N | Y | 230008450 | CHOP R |
| 230000652 | 230001194 | 1.66 | 56 | Neo-adjuvant (N) | 2015-07-19 | 2015-07-23 | Cisplatin + Doxorubicin | N | Y | 230008450 | GEMCITABINE |
| 230000653 | 230001194 | 1.76 | 56.4 | Not known (9) | 2017-02-08 | 2017-02-08 | CARBOPLATIN + ETOPOSIDE | 02 | null | 230008450 | BENDAMUSTINE + RITUXIMAB |
| 230000654 | 230000383 | null | null | Palliative (P) | 2014-05-08 | 2014-06-02 | Trial Unspecified | N | N | 230008519 | ABVD |
| 230000655 | 230000384 | 1.69 | 84.6 | Adjuvant (A) | 2016-01-10 | 2016-02-07 | Gemcitabine weekly | N | N | 230008529 | FLUOROURACIL + MITOMYCIN + RT |
| 230000656 | 230000384 | 1.66 | 68.1 | Not known (9) | 2013-05-23 | 2013-06-01 | CAPECITABINE + RT | null | null | 230008529 | GEMCARBO |
| 230000657 | 230000384 | 1.7 | 79 | Adjuvant (A) | null | 2013-11-17 | Capecitabine + Oxaliplatin 14day | 2 | N | 230008529 | CARBOPLATIN + ETOPOSIDE |
| 230000658 | 230000384 | 1.61 | 0 | Palliative (P) | 2019-01-07 | 2019-01-12 | AFATINIB | N | N | 230008529 | CAPECITABINE + OXALIPLATIN |
| 230000659 | 230000385 | 1.59 | 79.05 | Palliative (P) | 2013-09-09 | 2013-09-20 | Trial Unspecified | N | Y | 230008681 | DOCETAXEL |
| 230000660 | 230000386 | 1.78 | null | Adjuvant (A) | 2016-05-20 | 2016-06-09 | Capecitabine | 02 | N | 230008708 | CAPECITABINE + OXALIPLATIN |
| 230000661 | 230000387 | 1.76 | 69.1 | Palliative (P) | 2017-09-22 | 2017-09-24 | Capecitabine | N | null | 230008715 | LANREOTIDE |
| 230000662 | 230001196 | 1.6 | 88.4 | Palliative (P) | 2016-04-04 | 2016-04-18 | CAPECITABINE + MITOMYCIN + RT | 02 | N | 230008720 | CARBOPLATIN + PACLITAXEL |
| 230000663 | 230000388 | 0 | 63 | Disease modification (D) | 2015-02-02 | 2015-02-17 | FLUOROURACIL + MITOMYCIN + RT | 2 | N | 230008775 | CARBOPLATIN + ETOPOSIDE |
| 230000664 | 230000388 | null | 64.2 | Adjuvant (A) | 2015-01-17 | 2015-01-17 | Fluorouracil+Mitomycin+RT (Anal Ca) | 02 | N | 230008775 | CAPECITABINE + OXALIPLATIN |
| 230000665 | 230000389 | 1.7 | null | Curative (C) | 2018-01-23 | 2018-02-06 | CABOZANTINIB | N | N | 230008838 | CAPECITABINE + OXALIPLATIN |
| 230000666 | 230000389 | 1.55 | 92 | Curative (C) | 2015-03-25 | 2015-03-25 | Capecitabine | 02 | Y | 230008838 | CTD |
| 230000667 | 230001517 | 1.56 | 76.1 | Curative (C) | 2016-06-13 | 2016-06-14 | Capecitabine + Oxaliplatin 14day | 02 | N | 230008904 | BCG |
| 230000668 | 230001661 | 1.78 | 75.05 | Not known (9) | 2013-11-26 | 2013-11-30 | Capecitabine + Oxaliplatin 21day | 02 | N | 230008907 | CARBOPLATIN + ETOPOSIDE |
| 230000669 | 230000390 | 1.74 | 70 | Not known (9) | 2016-12-25 | 2017-01-12 | Carboplatin AUC 6 - 10 | N | N | 230008942 | SORAFENIB |